Viewing Study NCT07186868


Ignite Creation Date: 2025-12-24 @ 5:55 PM
Ignite Modification Date: 2026-01-05 @ 6:38 PM
Study NCT ID: NCT07186868
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-22
First Post: 2025-09-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: QL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical Cancer
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module